Get the Stockscreener App
2.97
3.13%
0.09
After Hours:
2.96
-0.01
-0.34%
Nyxoah Sa stock is traded at $2.97, with a volume of 33,866.
It is up +3.13% in the last 24 hours and down -16.57% over the past month.
Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.
See More
Previous Close:
$2.88
Open:
$2.95
24h Volume:
33,866
Relative Volume:
0.71
Market Cap:
$129.68M
Revenue:
$11.51M
Net Income/Loss:
$-101.84M
P/E Ratio:
-1.1118
EPS:
-2.6714
Net Cash Flow:
$-82.98M
1W Performance:
-1.33%
1M Performance:
-16.57%
6M Performance:
-40.48%
1Y Performance:
-54.24%
1-Day Range:
$2.8701
$2.97
1-Week Range:
$2.86
$3.02
52-Week Range:
$2.76
$8.64
Nyxoah Sa Stock (NYXH) Company Profile
Name
Nyxoah Sa
Sector
Industry
Phone
-
Address
-
Compare NYXH vs ISRG, BDX, MDLN, ALC, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NYXH
Nyxoah Sa
|
2.97 | 125.75M | 11.51M | -101.84M | -82.98M | -2.6714 |
ISRG
Intuitive Surgical Inc
|
451.38 | 160.21B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
144.17 | 41.62B | 21.92B | 1.76B | 2.63B | 6.1223 |
MDLN
Medline Inc
|
45.32 | 37.37B | 28.43B | 1.16B | 1.26B | 1.4457 |
ALC
Alcon Inc
|
74.45 | 35.82B | 10.40B | 980.00M | 1.61B | 1.9749 |
RMD
Resmed Inc
|
207.88 | 30.38B | 5.40B | 1.49B | 1.78B | 10.12 |
Nyxoah Sa Stock (NYXH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-31-23 | Initiated | H.C. Wainwright | Buy |
| Jul-19-23 | Initiated | Robert W. Baird | Neutral |
| Apr-21-22 | Initiated | Oppenheimer | Outperform |
| Apr-06-22 | Initiated | Wolfe Research | Peer Perform |
| Dec-21-21 | Resumed | Cantor Fitzgerald | Overweight |
| Jul-28-21 | Initiated | Cantor Fitzgerald | Overweight |
View All
Nyxoah Sa Stock (NYXH) Latest News
Nyxoah SA (NYXH) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release - Yahoo Finance
Nyxoah (NYXH) Earnings Date and Reports 2026 - MarketBeat
Nyxoah to Participate in the Bank of America 2026 Healthcare Conference - marketscreener.com
Nyxoah (NYXH) Jefferies 2024 Global Healthcare Conference Summary - Quartr
Nyxoah (NYXH) 2024 Cantor Fitzgerald Global Healthcare Conference Summary - Quartr
Nyxoah to Release First Quarter 2026 Financial Results on May 12, 2026 - The Manila Times
Nyxoah sets May 12 for Q1 results and 4:30 p.m. ET webcast - Stock Titan
Nyxoah SA Stock Rises Pre-Market After CMS Raises Reimbursement For Sleep Disorder Therapy - MSN
Nyxoah (NYXH) Stock Forecast & Price Target - Investing.com
Nyxoah SA (NYXH) Stock: Directional Bias Review | Q4 2025: EPS Misses ViewsSubscription Growth - Xã Châu Thành
NYXH (Nyxoah SA Ordinary Shares) posts 121 percent year over year revenue growth, shares rise 3.21 percent.EBITDA Margin - Cổng thông tin điện tử tỉnh Tây Ninh
Nyxoah SA (NYXH) Stock Position Trade (Grinds Higher) 2026-04-20Alpha Picks - Cổng thông tin điện tử tỉnh Lào Cai
Baird lowers its price target on Nyxoah SA (NYXH) to $4.62 from $5.87 - MSN
Nyxoah SA (NYXH) Stock Analysis: Exploring a 208% Potential Upside in the Medical Tech Sector - DirectorsTalk Interviews
Aug PreEarnings: Is Nyxoah SA forming bullish engulfing patterns2026 Price Momentum & AI Powered Trade Plan Recommendations - baoquankhu1.vn
How do market conditions affect Nyxoah SA (NYXH) Stock | Price at $2.87, Up 0.35%Community Volume Signals - Xã Thanh Hà
Nyxoah SA (NYXH) reports Q4 loss, misses revenue estimates - MSN
Baird Maintains Nyxoah SA(NYXH.US) With Hold Rating, Cuts Target Price to $4.62 - 富途牛牛
Today's Analyst Ratings for Nyxoah (NYXH): Stock Price Target Lo - GuruFocus
Stifel cuts Nyxoah stock price target to $8 on valuation review - Investing.com Canada
Stifel cuts Nyxoah stock price target to $8 on valuation review By Investing.com - Investing.com South Africa
Stifel Maintains Nyxoah SA(NYXH.US) With Buy Rating, Cuts Target Price to $8 - 富途牛牛
Nyxoah to Release Third Quarter 2024 Financial Results on November 6, 2024 - NTB Kommunikasjon
Market Overview: Can Nyxoah SA expand into new marketsPortfolio Gains Report & Consistent Profit Alerts - baoquankhu1.vn
Growth Review: Is now the right time to enter Nyxoah SA2026 Levels & AI Powered Market Trend Analysis - baoquankhu1.vn
Aug Breakouts: Will Nyxoah SA benefit from AI trendsWeekly Gains Report & AI Based Buy and Sell Signals - baoquankhu1.vn
NYXH Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Baird Lowers its Price Target on Nyxoah SA (NYXH) to $4.62 from $5.87 - Insider Monkey
Nyxoah’s Earnings Call Shows Rapid Growth, Rising Risks - TipRanks
NYXH PE Ratio & Valuation, Is NYXH Overvalued - Intellectia AI
Buyout Rumor: Is Nyxoah SA stock undervalued right now2026 Chart Watch & Technical Pattern Recognition Alerts - baoquankhu1.vn
Exit Recap: Will Nyxoah SA benefit from AI trendsEarnings Performance Report & Fast Exit Strategy with Risk Control - baoquankhu1.vn
Nyxoah SA (NASDAQ:NYXH) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Cantor Fitzgerald Initiates Nyxoah SA(NYXH.US) With Buy Rating, Announces Target Price $11 - 富途牛牛
[20-F] Nyxoah SA Files Annual Report (Foreign Issuer) | NYXH SEC FilingForm 20-F - stocktitan.net
Bull Run: Can Nyxoah SA ride the EV waveShare Buyback & Accurate Buy Signal Notifications - baoquankhu1.vn
Retail Trends: Is now the right time to enter Nyxoah SAMarket Risk Analysis & Long-Term Safe Return Strategies - baoquankhu1.vn
Breakout Zone: Is Nyxoah SA a speculative investment2026 Rallies & Entry Point Strategy Guides - baoquankhu1.vn
Nyxoah sees Q2 revenue up 73%, plans R&D shift to U.S. and Belgium; shares rise - MSN
Cantor Fitzgerald Reiterates Overweight Rating for NYXH, Price T - gurufocus.com
Cantor Fitzgerald reiterates Nyxoah stock rating on U.S. launch - Investing.com UK
Nyxoah's (NYXH) Overweight Rating Reaffirmed at Cantor Fitzgerald - MarketBeat
Stifel Maintains Nyxoah SA(NYXH.US) With Buy Rating, Cuts Target Price to $10 - 富途牛牛
New Highs: Will Nyxoah SA benefit from rising consumer demandQuarterly Risk Review & Reliable Intraday Trade Plans - baoquankhu1.vn
Nyxoah Details Early U.S. Genio Launch, Reimbursement Update at Oppenheimer MedTech Conference 2026 - MarketBeat
Nyxoah Discloses Taub Group’s 10.14% Stake After Threshold Crossing - TipRanks
Nyxoah Sa Stock (NYXH) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.78%
0.44%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):